FESIA Technology赞助的临床试验
总计4713个结果
-
Mbarara University of Science and Technology尚未招聘
-
Suzhou Puhe Pharmaceutical Technology Co., LTD尚未招聘
-
Huazhong University of Science and Technology尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘PD-L1阳性(CPS≥1)的复发或转移性宫颈癌
-
Pell Bio-Med Technology Co., Ltd.招聘中弥漫性大 B 细胞淋巴瘤 | 原发性纵隔大B细胞淋巴瘤 | 大 B 细胞淋巴瘤 | 滤泡性淋巴瘤 3B 级 | 滤泡性淋巴瘤 3A 级台湾
-
Huazhong University of Science and Technology尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘远端对称性多发性神经病 (DSPN)
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
Centre for Research and Technology Hellas招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中